Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant TNFRSF13C (Ianalumab Biosimilar) anticorps

Cet anticorps anti-TNFRSF13C (Ianalumab Biosimilar) est un anticorps Human Monoclonal détectant TNFRSF13C (Ianalumab Biosimilar) dans ELISA, FACS, BLI, Func et SPR. Adapté pour Humain.
N° du produit ABIN7581716

Aperçu rapide pour Recombinant TNFRSF13C (Ianalumab Biosimilar) anticorps (ABIN7581716)

Antigène

TNFRSF13C (Ianalumab Biosimilar)

Type d'anticorp

Recombinant Antibody

Reactivité

Humain

Hôte

  • 3
  • 1
Human

Clonalité

  • 4
Monoclonal

Conjugué

  • 2
  • 1
  • 1
Cet anticorp TNFRSF13C (Ianalumab Biosimilar) est non-conjugé

Application

ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    Fonction

    Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab)

    Séquence

    DIVLTQSPAT LSLSPGERAT LSCRASQFIS SSYLSWYQQK PGQAPRLLIY GSSSRATGVP ARFSGSGSGT DFTLTISSLE PEDFAVYYCQ QLYSSPMTFG QGTKVEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC,QVQLQQSGPG LVKPSQTLSL TCAISGDSVS SNSAAWGWIR QSPGRGLEWL GRIYYRSKWY NSYAVSVKSR ITINPDTSKN QFSLQLNSVT PEDTAVYYCA RYDWVPKIGV FDSWGQGTLV TVSSASTKGP SVFPLAPSSK STSGGTAALG CLVKDYFPEP VTVSWNSGAL TSGVHTFPAV LQSSGLYSLS SVVTVPSSSL GTQTYICNVN HKPSNTKVDK RVEPKSCDKT HTCPPCPAPE LLGGPSVFLF PPKPKDTLMI SRTPEVTCVV VDVSHEDPEV KFNWYVDGVE VHNAKTKPRE EQYNSTYRVV SVLTVLHQDW LNGKEYKCKV SNKALPAPIE KTISKAKGQP REPQVYTLPP SREEMTKNQV SLTCLVKGFY PSDIAVEWES NGQPENNYKT TPPVLDSDGS FFLYSKLTVD KSRWQQGNVF SCSVMHEALH NHYTQKSLSL SPGK

    Attributs du produit

    Anti-TNFRSF13C / BAFFR / CD268 Reference Antibody (ianalumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    Pureté

    >95 %

    Isotype

    IgG1
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Commentaires

    Therapeutic Agents by Target and Mechanism: BAFFR inhibitors

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Stock

    4 °C,-80 °C

    Stockage commentaire

    +4°C,-80°C
  • Antigène

    TNFRSF13C (Ianalumab Biosimilar)

    Classe de substances

    Biosimilar

    Poids moléculaire

    145.5 kDa

    UniProt

    Q96RJ3
Vous êtes ici:
Chat with us!